123 related articles for article (PubMed ID: 31746087)
41. Which one is a risk factor for chemotherapy-induced febrile neutropenia in childhood solid tumors: early lymphopenia or monocytopenia?
Oguz A; Karadeniz C; Ckitak EC; Cil V
Pediatr Hematol Oncol; 2006 Mar; 23(2):143-51. PubMed ID: 16651243
[TBL] [Abstract][Full Text] [Related]
42. Spurious white blood cell count from a new automated Sysmex XN hematology analyzer.
Tantanate C
Int J Lab Hematol; 2014 Dec; 36(6):e86-7. PubMed ID: 24628773
[No Abstract] [Full Text] [Related]
43. The Rate of Infectious Complications After Intrathecal Drug Delivery System Implant for Cancer-Related Pain Is Low Despite Frequent Concurrent Anticancer Treatment or Leukopenia.
Sindt JE; Larsen SD; Dalley AP; Collier WH; Brogan SE
Anesth Analg; 2020 Jul; 131(1):280-287. PubMed ID: 31990731
[TBL] [Abstract][Full Text] [Related]
44. Community paramedic point of care testing: validity and usability of two commercially available devices.
Blanchard IE; Kozicky R; Dalgarno D; Simms J; Goulder S; Williamson TS; Biesbroek S; Page L; Leaman K; Snozyk S; Redman L; Spackman K; Doig CJ; Lang ES; Lazarenko G
BMC Emerg Med; 2019 May; 19(1):30. PubMed ID: 31046680
[TBL] [Abstract][Full Text] [Related]
45. Pretreated baseline neutrophil count and chemotherapy-induced neutropenia may be conveniently available as prognostic biomarkers in advanced gastric cancer.
Chen Z; Chen W; Wang J; Zhu M; Zhuang Z
Intern Med J; 2015 Aug; 45(8):854-9. PubMed ID: 25871806
[TBL] [Abstract][Full Text] [Related]
46. Outcome of febrile neutropenic patients on granulocyte colony stimulating factor in a tertiary care hospital.
Osmani AH; Ansari TZ; Masood N; Ahmed B
Asian Pac J Cancer Prev; 2012; 13(6):2523-6. PubMed ID: 22938399
[TBL] [Abstract][Full Text] [Related]
47. Microbiological point of care testing before antibiotic prescribing in primary care: considerable variations between practices.
Haldrup S; Thomsen RW; Bro F; Skov R; Bjerrum L; Søgaard M
BMC Fam Pract; 2017 Jan; 18(1):9. PubMed ID: 28125965
[TBL] [Abstract][Full Text] [Related]
48. Comparability of Point-of-Care versus Central Laboratory Hemoglobin Determination in Emergency Patients at a Supra-Maximal Care Hospital.
Dolscheid-Pommerich RC; Dolscheid S; Grigutsch D; Stoffel-Wagner B; Graeff I
PLoS One; 2016; 11(11):e0166521. PubMed ID: 27880783
[TBL] [Abstract][Full Text] [Related]
49. Comparison of the use of comprehensive point-of-care test panel to conventional laboratory process in emergency department.
Kankaanpää M; Holma-Eriksson M; Kapanen S; Heitto M; Bergström S; Muukkonen L; Harjola VP
BMC Emerg Med; 2018 Nov; 18(1):43. PubMed ID: 30453888
[TBL] [Abstract][Full Text] [Related]
50. Evaluating the total costs of chemotherapy-induced febrile neutropenia: results from a pilot study with community oncology cancer patients.
Bennett CL; Calhoun EA
Oncologist; 2007 Apr; 12(4):478-83. PubMed ID: 17470690
[TBL] [Abstract][Full Text] [Related]
51. Biological and clinical correlates after chemotherapy and granulocyte colony-stimulating factor administration.
Higa GM; DeVore RF; Auber ML; Lynch JP; Landreth KS
Pharmacotherapy; 1998; 18(1):1-8. PubMed ID: 9469674
[TBL] [Abstract][Full Text] [Related]
52. Hematologic predictors of bone marrow recovery in neutropenic patients hospitalized for fever: implications for discontinuation of antibiotics and early discharge from the hospital.
Griffin TC; Buchanan GR
J Pediatr; 1992 Jul; 121(1):28-33. PubMed ID: 1625089
[TBL] [Abstract][Full Text] [Related]
53. Economic study of neutropenia induced by myelotoxic chemotherapy.
Montero MC; Valdivia ML; Carvajal E; Montaño A; Buenestado C; Lluch A; Atienza M
Pharm World Sci; 1994 Aug; 16(4):187-92. PubMed ID: 7951132
[TBL] [Abstract][Full Text] [Related]
54. Plasma IL-8 and IL-6 levels can be used to define a group with low risk of septicaemia among cancer patients with fever and neutropenia.
de Bont ES; Vellenga E; Swaanenburg JC; Fidler V; Visser-van Brummen PJ; Kamps WA
Br J Haematol; 1999 Nov; 107(2):375-80. PubMed ID: 10583227
[TBL] [Abstract][Full Text] [Related]
55. Rapid testing of red blood cell parameters in primary care patients using HemoScreen™ point of care instrument.
Larsson A; Carlsson L; Karlsson B; Lipcsey M
BMC Fam Pract; 2019 Jun; 20(1):77. PubMed ID: 31174471
[TBL] [Abstract][Full Text] [Related]
56. Neulasta. Boosting WBC counts during chemotherapy.
Nursing; 2002 May; 32(5):18. PubMed ID: 12035638
[No Abstract] [Full Text] [Related]
57. Use of oral mucosal neutrophil counts to detect the onset and resolution of profound neutropenia following high-dose myelosuppressive chemotherapy.
Akpek G; Knight RD; Wright DG
Am J Hematol; 2003 Jan; 72(1):13-9. PubMed ID: 12508262
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of the mechanisms of antiepileptic drug-related chronic leukopenia.
O'Connor CR; Schraeder PL; Kurland AH; O'Connor WH
Epilepsia; 1994; 35(1):149-54. PubMed ID: 8112238
[TBL] [Abstract][Full Text] [Related]
59. Thrombolysis in stroke patients: Comparability of point-of-care versus central laboratory international normalized ratio.
Dolscheid-Pommerich RC; Dolscheid S; Eichhorn L; Stoffel-Wagner B; Graeff I
PLoS One; 2018; 13(1):e0190867. PubMed ID: 29320558
[TBL] [Abstract][Full Text] [Related]
60. Impact of point-of-care testing for white blood cell count on triage of patients with infection in the remote Northern Territory of Australia.
Spaeth B; Shephard M; Kokcinar R; Duckworth L; Omond R
Pathology; 2019 Aug; 51(5):512-517. PubMed ID: 31262564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
